The Bulletin
The Times


.

Insilico Medicine Announces Positive Topline Results of ISM001-055 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) Developed Using Generative AI

  • Written by PR Newswire

Highlights:

  • ISM001-055 was safe and well-tolerated with a favorable PK profile in IPF patients
  • Patients who received ISM001-055 showed dose-dependent improvement in the efficacy endpoint, as measured by change in forced vital capacity (FVC) at 12 weeks

CAMBRIDGE, Mass., Nov. 12, 2024 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage...

hacklink deneme bonusuPadişahbetvippark kayıtPadişahbetjustin tvlunabet girişPadişahbettaraftarium24Sahabetjojobetjojobetjojobetviljo kasinot kirjautuminenGalabetzimpler kasinotGalabetkralbetjojobetcasibomcasibommarsbahistaraftarium24taraftariumjojobetjojomeritking